Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $5.8M | $863.0K | $1.1M | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $5.8M | $863.0K | $1.1M | $0 |
| Gross margin | 100.0% | 100.0% | 100.0% | — |
| R&D | $15.7M | $19.6M | $36.5M | $62.6M |
| Operating income | −$13.5M | −$23.7M | −$47.6M | −$88.2M |
| EBITDA | −$12.2M | −$22.9M | −$48.6M | −$83.0M |
| Net income | −$13.0M | −$23.8M | −$48.5M | −$81.7M |
| Net margin | -224.5% | -2752.3% | -4308.6% | — |
| EPS (diluted) | -0.56 | -1.02 | -3.91 | -2.07 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds DICE.
No tracked institution reports a position in DICE as of their last filing.
No one on the platform has traded DICE yet.
| $1.8B |
| — |
| KDNYChinook Therapeutics, Inc. | $40.39 | +0.22% | $2.7B | — |
| LBPHLongboard Pharmaceuticals, Inc. | $59.98 | — | $2.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$DICE DICE Therapeutics, Inc. (NASDAQ:DICE): A Promising Biopharmaceutical Company Poised for Growth https://beyondspx.com/article/dice-therapeutics-inc-nasdaq-dice-a-promising-biopharmaceutical-company-poised-for-growth
View on StockTwits ↗BTIG⬆️PT $PTGX $67 was $51/Buy, after ascribing💳to PN-881 based on the implied EV of $DICE's ACQ by $LLY, (on only P1 data), risk adj'd by 50%. BTIG thinks PN-881's differentiated specificity could support preferential positioning as the dominant oral IL-17 inhibitor: $ucbjy $nvs
View on StockTwits ↗$DICE DICE Therapeutics, Inc. (NASDAQ:DICE): A Promising Biopharmaceutical Company Poised for Growth http://beyondspx.com/2024/08/04/dice-therapeutics-inc-nasdaqdice-a-promising-biopharmaceutical-company-poised-for-growth/
View on StockTwits ↗$PRQR By "like these" he meant $DICE and $MORF deals, early ish stage assets, novel science.
View on StockTwits ↗$NERV - Investment perspective on Minerva Neurosciences vs. Dice Molecules ( $DICE ) in September 2023. Next fiscal quarter end is on 30th of September 2023 https://www.macroaxis.com/competition/NERV/DICE/Minerva-vs-Dice #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗$NVO, $DICE and $BLDR. Strong technicals stocks and near a new high. https://www.chartmill.com/stock/stock-screener?sid=16&f=p_pg10,v1_50b500,s_str,s_nnh,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=720&cl=F&o1=3&o2=3&o3=1&op1=200,16711680&op2=50,255&utm_source=Strong_Stocks_near_New_High&utm_medium=stocktwits&utm_campaign=screen
View on StockTwits ↗DICE Therapeutics's neutral rating reiterated at HC Wainwright. $48.00 PT. www.marketbeat.com/stocks/NASDAQ/DICE/price-target/ $DICE
View on StockTwits ↗DICE Therapeutics, Inc. Files SEC Form 8-K $DICE https://www.marketbeat.com/stocks/NASDAQ/DICE/sec-filings/
View on StockTwits ↗$LLY $DICE Lilly Completes Acquisition of DICE Therapeutics https://www.stocktitan.net/news/LLY/lilly-completes-acquisition-of-dice-nbus3ix4jls2.html
View on StockTwits ↗$NVTAQ - Should I Trade Invitae Corp and take over Dice Molecules Holdings ( $DICE ) in September? Next financial report is on 14th of November 2023 https://www.macroaxis.com/invest/pair-correlation/NVTA/DICE/Invitae-vs-Dice #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗$DICE trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $47.59 Vol: 4.33M.
View on StockTwits ↗$DRUG - What is better Bright Minds or Dice Molecules ( $DICE )? https://www.macroaxis.com/competition/DRUG/DICE/Bright-vs-Dice #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗From 7/5/2023, looking back across 22 Month-Ends for DICE, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $DICE #DICE #DICEStock #TickerDD #DICEPrice https://www.youtube.com/watch?v=-2146826273
View on StockTwits ↗New 52 week highs for $DICE, $BA and $MAR https://www.chartmill.com/stock/stock-screener?f=p_pg10,v1_50b500,s_nh,exch_us&v=3&utm_source=stocktwits&utm_medium=New_52_week_high_today&utm_content=screener&utm_campaign=social_tracking
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.